Join the Public Health Club 

In this episode of The Dr. Des Show, Dr. Desiree “Dr. Des” Strickland challenges the narrow narratives that often define public health career paths. Speaking directly to professionals who feel boxed into government, nonprofit, or academic roles, Dr. Des opens the door to biopharmaceutical careers that meaningfully align with public health training—while also offering expanded influence, competitive compensation, and long-term growth.

This episode goes beyond simply naming alternative roles. Dr. Des focuses on the strategic repositioning required to move into biopharma, emphasizing that success is less about acquiring new skills and more about learning how to translate existing public health experience into industry-relevant language. Listeners are guided through how to reframe their work so it resonates with hiring managers, recruiters, and cross-functional teams in the biopharmaceutical space.

Dr. Des breaks down three specific biopharma roles—Real World Evidence Scientist, Medical Science Liaison, and Patient Advocacy & Engagement Lead—explaining what each role actually involves and why public health professionals are well suited for them. A recurring theme throughout the episode is intentional preparation over blind applying. Rather than abandoning public health values, Dr. Des shows how professionals can pivot strategically while maintaining their commitment to equity, evidence, and population-level impact.

5 Key Takeaways

1. Public health careers extend beyond traditional sectors, with biopharma offering roles that value public health expertise when it is positioned effectively.
2. Real World Evidence roles heavily leverage public health skills such as study design, data analysis, and translating findings into actionable insights.
3. Medical Science Liaison roles are not sales positions, but strategic scientific communication roles that reward strong stakeholder engagement and data storytelling.
4. Patient Advocacy and Engagement roles closely align with public health values like equity, access, and lived experience, but require industry-specific framing.
5. The biggest barrier to entering biopharma is not lack of qualifications, but failure to translate public health experience into outcomes-, evidence-, and strategy-focused language.

https://www.drdesshow.com/

https://www.publichealthclub.com/